Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genetic fingerprints help predict sarcoma outcome:

This article was originally published in Clinica

Executive Summary

US researchers have developed a genetic fingerprint of each type of adult soft tissue sarcoma, which they say will improve their diagnosis and enhance the prediction of patient outcome. The genetic fingerprints, which were identified using oligonucleotide array analysis, will be useful in cases where pathologists disagree about a diagnosis or when the appearance of tumour cells does not conclusively link them to a particular subtype, say researchers led by Dr Robert Maki, of the Memorial Sloan-Kettering Cancer Center in New York.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066598

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel